Funding from the National Institute of Allergy and Infectious Diseases (NIAID) will expand Hesperos’ physiologically relevant Malaria-on-a-Chip model to bridge critical translational gaps and accelerate the evaluation of next-generation antimalarial therapies. ORLANDO, FLORIDA, 22 October 2026: … Read More